Desk-sized fusion reactors could solve medical isotope crisis for cancer diagnosis
SMRTR summary
Astral Systems, a UK startup, aims to address the medical isotope shortage with desk-sized fusion reactors using multistate fusion technology. The company secured £4.5M to commercialize its approach, which promises more efficient and cost-effective isotope production than traditional reactors, potentially improving cancer diagnosis and treatment accessibility.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article